Conversely, it was recently shown that human melanoma secretomes drive the expression of many NF-κB-dependent genes in B cells, including activation markers and co-stimulation molecules such as CD69, CD30 or CD137, as well as chemokines such as CCL3 or CCL4 [112]. The gene discussed is NFKB1; the disease is melanoma.